At PI Medical, we are committed to providing the latest technologies and tools for medical diagnostics. Isoprotrace is one of the products we offer in the fight against prostate cancer. This product is designed to optimize the detection and treatment of this disease. In 2024, the Isoprotrace PSMA-11 kit has received marketing authorization in the Netherlands.
Isoprotrace is a groundbreaking radiodiagnostic agent used for positron emission tomography (PET) in prostate cancer. It utilizes Gallium (68Ga) Gozetotide, a tracer that specifically targets prostate-specific membrane antigen (PSMA). PSMA is a protein that is highly expressed on prostate cancer cells, making Isoprotrace extremely effective in detecting tumors and metastases.
(Continue reading below)
Isoprotrace has been developed for use in various stages of prostate cancer, such as primary staging. It is intended for patients at high risk of metastasis. Isoprotrace helps determine the extent of the disease and plan treatment. For patients with elevated PSA levels following prior curative therapy, Isoprotrace also offers an accurate method for detecting and localizing recurrence. Finally, Isoprotrace is effective in identifying small lymph node metastases and bone metastases that may not be visible on conventional CT scans.
Would you like more information about Isoprotrace, or are you curious about the possibilities? Use the form to request more information. As the official distributor of Isoprotrace in the Netherlands, we would be happy to assist you with a no-obligation consultation. Contact us now!
Disclaimer: Isoprotrace has been approved for use in the EU and is awaiting approval in other countries.
Easy to prepare:
Isoprotrace comes in a ready-to-use kit. Unlike other methods, there is no need for complicated synthesis equipment or additional reagents. The preparation requires no pH adjustments or heating. This significantly simplifies and speeds up the process. The entire preparation takes an average of only 5 minutes, compared to the average of 15–20 minutes for traditional methods.
High efficiency and purity:
The kit delivers a radiochemical purity of ≥ 99%. This underscores the accuracy of the diagnostic results. Thanks to the short preparation time with Isoprotrace, the eluted radioactivity is utilized more efficiently, which means you can perform more procedures with the same kit.
Safety in use:
Isoprotrace is clinically approved and meets the strictest safety standards, including sterilization and low endotoxin levels. The risk of side effects is minimal, with only mild to moderate reactions such as fatigue and skin rashes occurring rarely.
Time and cost savings:
Thanks to its simple preparation and high efficiency, Isoprotrace saves not only time but also money. Less preparation means fewer labor hours and lower operating costs.
Geen complexe apparatuur nodig:
Isoprotrace elimineert de behoefte aan dure en complexe synthesemodules, wat het ook toegankelijk maakt kleinere medische instellingen, zoals onafhankelijke klinieken.
High precision in diagnostics:
With its high radiochemical purity and consistent results, Isoprotrace ensures a reliable and accurate diagnosis of prostate cancer.
